Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 3/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15489983 | 0.94 | TLR8 (0.34) | MAOAHTR2AHRH1 | |
| SCHEMBL20565391 | 0.87 | MAOA (0.35) | MAOAHTR2AHRH1KIF11KCNH2 | |
| SCHEMBL20000036 | 0.86 | MAOA (0.34) | MAOAHTR2AHRH1KIF11KCNH2 | |
| SCHEMBL12546076 | 0.84 | MAOA (0.33) | MAOAHTR2AHRH1KIF11KCNH2 | |
| SCHEMBL13878405 | 0.84 | MAOA (0.33) | MAOAHTR2AHRH1KIF11KCNH2 | |
| SCHEMBL3418590 | 0.84 | HRH1 (0.36) | MAOAHTR2AHRH1KIF11KCNH2 | |
| SCHEMBL13878406 | 0.83 | MAOA (0.32) | MAOAHTR2AHRH1KIF11KCNH2 | |
| SCHEMBL12695267 | 0.83 | MAOA (0.32) | MAOAHTR2AHRH1KIF11KCNH2 | |
| SCHEMBL676715 | 0.80 | MAOA (0.31) | MAOAHTR2AHRH1 | |
| SCHEMBL12634222 | 0.80 | HTR2A (0.33) | MAOAHTR2AHRH1TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024039914-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | GENERAL ELECTRIC TECHNOLOGY GMBH (CH) | 2024-02-22 | — | — | WO | disclosed |
| US-9914098-B2 | Flux enhancing agent for improving composite polyamide reverse osmosis membrane performance | BL TECHNOLOGIES, INC. | 2018-03-13 | — | — | US | disclosed |
| US-9914098-B2 | Flux enhancing agent for improving composite polyamide reverse osmosis membrane performance | BL TECHNOLOGIES, INC. | 2018-03-13 | — | — | US | disclosed |
| US-20160193572-A1 | Novel Flux Enhancing Agent for Improving Composite Polyamide Reverse Osmosis Membrane Performance | BL TECHNOLOGIES, INC. | 2016-07-07 | — | — | US | disclosed |
| US-20160193572-A1 | Novel Flux Enhancing Agent for Improving Composite Polyamide Reverse Osmosis Membrane Performance | BL TECHNOLOGIES, INC. | 2016-07-07 | — | — | US | disclosed |
| US-9346023-B2 | Flux enhancing agent for improving composite polyamide reverse osmosis membrane performance | GENERAL ELECTRIC COMPANY (US) | 2016-05-24 | — | — | US | disclosed |
| US-20140054228-A1 | Novel Flux Enhancing Agent for Improving Composite Polyamide Reverse Osmosis Membrane Performance | GENERAL ELECTRIC COMPANY (US) | 2014-02-27 | — | — | US | disclosed |
| US-8030509-B2 | Carbon dioxide absorbent and method of using the same | GENERAL ELECTRIC COMPANY (US) | 2011-10-04 | — | — | US | disclosed |
| US-8030509-B2 | Carbon dioxide absorbent and method of using the same | GENERAL ELECTRIC COMPANY (US) | 2011-10-04 | — | — | US | disclosed |
| WO-2011014273-A1 | CARBON DIOXIDE ABSORBENT AND METHOD OF USING THE SAME | GENERAL ELECTRIC COMPANY (US) | 2011-02-03 | — | — | WO | disclosed |
| US-20100158777-A1 | CARBON DIOXIDE ABSORBENT AND METHOD OF USING THE SAME | GENERAL ELECTRIC COMPANY (US) | 2010-06-24 | — | — | US | disclosed |
| US-20100158777-A1 | CARBON DIOXIDE ABSORBENT AND METHOD OF USING THE SAME | GENERAL ELECTRIC COMPANY (US) | 2010-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100158777-A1 | CARBON DIOXIDE ABSORBENT AND METHOD OF USING THE SAME | MCM4, MCM5, IPO4 | MAOA 2506/4885HTR2A 3015/4885HRH1 2736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.